Cargando…

Idiopathic fourth ventricle outlet obstruction successfully treated by endoscopic third ventriculostomy: a case report

INTRODUCTION: Fourth ventricle outlet obstruction (FVOO) is a rare cause of obstructive hydrocephalus. We describe a case of idiopathic FVOO that was successfully treated with endoscopic third ventriculostomy (ETV). CASE REPORT: A 3-year old boy without any remarkable medical history presented with...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishi, Yukitomo, Asaoka, Katsuyuki, Kobayashi, Hiroyuki, Motegi, Hiroaki, Sugiyama, Taku, Yokoyama, Yuka, Echizenya, Sumire, Itamoto, Koji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4627988/
https://www.ncbi.nlm.nih.gov/pubmed/26543700
http://dx.doi.org/10.1186/s40064-015-1368-x
Descripción
Sumario:INTRODUCTION: Fourth ventricle outlet obstruction (FVOO) is a rare cause of obstructive hydrocephalus. We describe a case of idiopathic FVOO that was successfully treated with endoscopic third ventriculostomy (ETV). CASE REPORT: A 3-year old boy without any remarkable medical history presented with a headache and vomiting. Computed tomography (CT) images, which had incidentally been taken 2 years previously due to a minor head injury, showed no abnormality. Magnetic resonance imaging on admission showed tetra-ventricular hydrocephalus associated with the dilatation of the fourth ventricle outlets, without any obstructive lesions. However, CT ventriculography, involving contrast medium injection through a ventricular catheter, suggested mechanical obstruction of the cerebrospinal fluid (CSF) at the fourth ventricle outlets. Thus, the patient was diagnosed with FVOO and ETV was performed; the hydrocephalus was subsequently resolved. Although hydrocephalus recurred 1 year postoperatively, re-ETV for the highly stenosed fenestration successfully resolved this condition. CONCLUSIONS: ETV should be considered for FVOO treatment, particularly in idiopathic cases without CSF malabsorption.